Vital KSK Holdings, Inc.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2016/02/04 | ¥30.31 | ¥49.91 | +64.7% |
| 2015/08/04 | ¥15.11 | ¥16.60 | +9.8% |
| 2015/05/13 | ¥8.69 | ¥8.51 | -2.0% |
| 2015/02/04 | ¥21.81 | ¥27.24 | +24.9% |
Shareholder Composition
Updated 2026/10/01Top Mutual Funds / ETFs
Updated 2026/10/01Major Holders
Updated 2026/10/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
479.0K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
358.6K | 0.00% | |
|
American Century ETF Trust-Avantis International Small Cap Value ETF
|
238.8K | +7.13% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
218.1K | +0.97% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
196.4K | 0.00% | |
|
Dimensional ETF Trust-Dimensional International Small Cap Value ETF
|
188.4K | 0.00% |
Dividend History 2Years Growth
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥71 | +22.4% |
| 2025 | ¥58 | +31.8% |
| 2024 | ¥44 | -4.3% |
| 2023 | ¥46 | +76.9% |
| 2022 | ¥26 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥581,327M | ¥587,481M | ¥600,370M | ¥610,497M |
| Gross Profit | ¥46,517M | ¥48,301M | ¥49,214M | ¥49,581M |
| Operating Income | ¥4,025M | ¥5,556M | ¥5,706M | ¥4,028M |
| Pretax Income | ¥8,207M | ¥8,775M | ¥10,772M | ¥11,570M |
| Net Income | ¥4,831M | ¥5,843M | ¥7,308M | ¥7,362M |
| EPS | ¥92.69 | ¥115.03 | ¥149.02 | ¥152.29 |
| Operating Margin | 0.69% | 0.95% | 0.95% | 0.66% |
| Balance Sheet | ||||
| Total Assets | ¥297,316M | ¥317,258M | ¥299,426M | ¥320,568M |
| Total Equity | ¥98,985M | ¥104,663M | ¥105,913M | ¥117,222M |
| Total Liabilities | ¥198,331M | ¥212,595M | ¥193,513M | ¥203,346M |
| Cash | ¥19,029M | ¥34,712M | ¥23,099M | ¥22,953M |
| Interest-bearing Debt | ¥10,248M | ¥9,114M | ¥7,699M | ¥6,779M |
| Equity Ratio | 33.29% | 32.99% | 35.37% | 36.57% |
| D/E Ratio | 0.10 | 0.09 | 0.07 | 0.06 |
| Cash Flow | ||||
| Operating CF | -¥3,001M | ¥23,570M | -¥8,024M | ¥4,833M |
| Investing CF | -¥1,038M | -¥1,822M | ¥3,516M | -¥1,071M |
| Financing CF | -¥4,080M | -¥5,769M | -¥6,543M | -¥4,399M |
| Free CF | -¥9,600M | ¥18,472M | -¥12,361M | -¥435M |
| Efficiency | ||||
| ROE | 4.88% | 5.58% | 6.90% | 6.28% |
| ROA | 1.62% | 1.84% | 2.44% | 2.30% |
Latest IR Information
-
Notice Regarding Status of Treasury Stock Acquisitions
Discloses status of treasury stock acquisitions. Total number of ordinary shares acquired: 140,400 shares; total amount: 226,973,996 yen. Acquisition period: September 1, 2026 to September 30, 2026; method: market purchase. A prior board resolution set maximum limits of 2,000,000 shares...
Read more -
Notice Regarding Share Buyback Status
Shares acquired: 195,100 common shares, total amount 317,019,391 yen. Acquisition period: 2026/8/1–2026/8/31 (executed on a trading basis), conducted through market purchases. Previously approved by the board of directors: up to 2,000,000 shares and up to 4,000,000,000 yen, with acquisition period...
Read more -
First Quarter Financial Results for the Fiscal Year Ending March 2027 (Japanese GAAP) (Consolidated)
Consolidated results for the first quarter of the fiscal year ending March 2027. Disclosures include sales and performance by segment, trends in net income and operating income, and key financial status. Contributions from new businesses and product lines, changes in...
Read more -
Notice Regarding Share Buyback (Acquisition of Treasury Stock under Company Law Article 165, Paragraph 2)
Treasury shares of common stock were acquired by market purchases of 241,500 shares from July 1 to July 31. Total acquisition amount is 386,741,190 yen. Previously approved by the board of directors to acquire up to 2,000,000 shares. Cumulative acquisitions...
Read more -
Notice of Recording of Investment Securities Sale Profit | July 2026
Our two consolidated subsidiaries have sold listed stocks they hold, recording an investment securities sale profit of 8,100 million yen. The reason for the sale is asset optimization and strengthening of financial health. There is no change to the earnings...
Read more
Latest News (5 items)
Company Information
About
Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals for scientific use. It is also involved in the operation pharmacies; provision of medical management consulting services for medical institutions such as hospitals, nursing care providers, and local governments; wholesale of agricultural chemicals and agricultural materials; nursing care-related business; rental and sales of welfare equipment and home modification; general freight vehicle transportation activities; and insurance agency, real estate management, and parking lot operation businesses. Vital KSK Holdings, Inc. was incorporated in 2009 and is headquartered in Setagaya, Japan.
